COVID-19 increases risk of mortality in patients with hip fracture

Objectives:
Does hip fracture increase risk of mortality among COVID-19 patients?

Study design:
This review article included 6 studies with a total of 984 participants.
Regression-based Harbord's test showed no indication of small-study effects [p = 0.06].  

Results and conclusions:   
The investigators found pooled prevalence of COVID-19 was 9% [95% CI = 7% to 11%].

The investigators found the mortality rate in patients with concomitant hip fracture and COVID-19 was 36% [95% CI = 26% to 47%], whereas the mortality rate in hip fracture without COVID-19 was 2% [95% CI = 1% to 3%].

The investigators found meta-analysis showed that COVID-19 was associated with a seven-fold increase in risk [RR = 7.45, 95% CI = 2.72 to 20.43, p 0.001, I2 = 68.6%] of mortality in patients with hip fracture.

The investigators concluded COVID-19 is associated with an increased risk of mortality in patients with hip fracture.

Original title:
Coronavirus disease 2019 (COVID-19) markedly increased mortality in patients with hip fracture - A systematic review and meta-analysis by Lim MA and Pranata R.

Link:
https://pubmed.ncbi.nlm.nih.gov/32958988/

Additional information of El Mondo:
Find more information/studies on coronavirus right here.